| April Dawn Easterwood I, | |
|
118 E Choccolocco St, Oxford, AL 36203-1222 | |
| (256) 831-4601 | |
| (256) 835-3386 |
| Full Name | April Dawn Easterwood I |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 118 E Choccolocco St, Oxford, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265019442 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 2-055457 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| April Dawn Easterwood I, 118 E Choccolocco St, Oxford, AL 36203-1222 Ph: (256) 831-4601 | April Dawn Easterwood I, 118 E Choccolocco St, Oxford, AL 36203-1222 Ph: (256) 831-4601 |
News Archive
Eighty-four percent of children 18 and younger had successful clinical outcomes during an eight year follow-up to repair a torn meniscus (cartilage that provides cushioning to distribute your body weight across the knee joint) at the same time as reconstruction of the anterior cruciate ligament (ACL), according to a new study presented today at the American Orthopaedic Society for Sports Medicine's Specialty Day in New Orleans, (March 13).
Bionovo, Inc. announced today that it has received final guidance from the European Medicines Agency (EMA) in order to advance Menerba, the company's lead drug candidate for menopausal symptoms, to Phase 3 clinical trials in Europe. The guidance defines the clinical and regulatory pathway to a European marketing authorization for Menerba.
Ancora Heart, Inc., a company developing a novel therapy to address heart failure, today announced positive clinical data from the company's recently expanded U.S. early feasibility study evaluating the safety of the investigational AccuCinch Ventricular Repair System designed for the treatment of heart failure and functional mitral regurgitation.
Brush Engineered Materials Inc. today announced it will change its name to Materion Corporation and unify all of its businesses under the new name effective March 8, 2011. The Company's common stock will continue to trade on the New York Stock Exchange.
Consumers Union, the nonprofit publisher of Consumer Reports, expressed disappointment with the U.S. Food & Drug Administration's (FDA) failure to ban the chemical bisphenol A (BPA), despite announcing today that there is cause for concern over its potential effect on children. Consumers Union believes that that there is enough scientific evidence to date to warrant a ban on BPA in food contact products now.
› Verified 4 days ago
Jaime Turner Hall, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 118 E Choccolocco St, Oxford, AL 36203 Phone: 256-831-4601 | |
Kenyetta L Thomas, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 318 Snow St Ste E, Oxford, AL 36203 Phone: 470-880-1953 | |
Courtney Butterworth, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 118 E Choccolocco St, Oxford, AL 36203 Phone: 256-831-4601 | |
Mrs. Jennifer Lynn Pierce, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 118 E Choccolocco St, Oxford, AL 36203 Phone: 256-831-4601 Fax: 256-835-3386 | |
Mrs. Annette Funnichello Buggs, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 118 E Choccolocco St, Oxford, AL 36203 Phone: 256-831-4601 Fax: 256-835-3386 |